Abstract- Candida glabrata was thought to be a primarily non-pathogenic organism. However, with the ever-increasing population of immunocompromised individuals, it is considered to be an opportunistic pathogen. Patients with spinal cord injuries often using a long-term urinary catheter and are high risk for Urinary Tract Infections. This case report describes a patient with spinal cord injury (thoracic region) with a pure culture of Candida glabrata in a urine sample.
© 2015 Tehran University of Medical Sciences. All rights reserved.
Acta Med Iran 2015;53(8):516-517.
Keywords: Candida glabrata; Urinary tract infection; Spinal cord injury
Introduction
Candida glabrata (C. glabrata) is a haploid yeast of the genus Candida, previously known as Torulopsis glabrata. This species of yeast is non-dimorphic, and no mating activity has been observed. Until recently, C. glabrata was thought to be a primarily non-pathogenic organism. However, with the ever-increasing population of immunocompromised individuals, trends have shown C. glabrata to be a highly opportunistic pathogen of the urogenital tract and of the bloodstream. There are two widely cited potential virulence factors that contribute to the pathogenicity of C. glabrata. The first is a series of adhesins coded by the EPA (epithelial adhesin) genes. These genes, located in the subtelomeric region, can respond to environmental cues that allow them to be expressed en masse so the organism and adhere to biotic and abiotic surfaces in microbial mats. This is also the suspected mechanism by which C. glabrata forms microbial "biofilms" on urinary catheters (1). Cultures are an effective method for identifying C. glabrata. The culture may take several days to grow, but the identification of the yeast species is quick once the yeast is isolated.
A spinal cord injury (SCI) refers to any injury to the spinal cord that is caused by trauma instead of disease. Depending on where the spinal cord and nerve roots are damaged, the symptoms can vary widely from pain to paralysis to incontinence. SCI has many causes, but are typically associated with major trauma from motor vehicle accidents, falls, sports injuries, and violence (2). Based on American Spinal Injury Association (ASIA) calssification, Spinal cord injuries are described at various levels of "incomplete", which can vary from having no effect on the patient to a "complete" injury which means a total loss of function. Determining the exact "level" of injury is critical in making accurate predictions about the specific parts of the body that may be affected by paralysis and loss of function. The level is assigned according to the location of the injury by the vertebra of the spinal column closest to the injury on the spinal cord. Spinal injuries are divided into three categories: cervical, thoracic, and lumbosacral injuries (3).
Case Report
A 48-year-old man was admitted to "Brain and spinal injury repair research centre" in Emam Khomeini Hospital, Tehran University of Medical Sciences. He complained of fever, chills and no other Urinary Tract Infection (UTI) symptoms. He had fallen from a height on March 2013 and since then used a urinary catheter. There was injury to thoracic spinal cord (T12) and in ASIA calcification was belong to category A. A indicates a "complete" spinal cord injury where no motor or sensory function is preserved in the sacral segments S4-S5 in history of patient; he did not have UTI or take any Antibiotic. The catheter port was cleaned with 70% alcohol, and 10 ml urine was collected using a needle and syringe and was referred to Microbiology laboratory and were analyzed with biochemical and microbiological investigations. Urine sample was plated on specific and nonspecific culture media included Blood agar, E.M.B agar and Mac Conkey agar. In the microscopic investigation, the specimen was showing the presence of puss cell (>5/HPF), hematuria (more than 50 RBC/HPF) and pyuria (Many WBC/HPF) but without any bacteria. There was a pure culture of cloudy white colonies with 2-3 mm diameter on media cultures (>100000 CFU/ml). In a microscopic survey of colonies with gram stain, there was pure yeast form of fungi. The colonies were subcultured on fungi specific culture media and were identified with biochemical tests. Sugar assimilation was performed by an auxanographic technique using yeast nitrogen base and various carbohydrates (glucose, galactose, sucrose, maltose, xylose and trehalose). C. glabrata assimilates glucose and trehalose (4). The results show that the microorganism agent of UTI in this patient was C. glabrata. The isolated C. glabrata was tested for antifungal susceptibility testing by disc diffusion method.
Discussion
UTI is the most common infections in spinal cord injuries patients. About 10% to 15% of UTIs are because of Candida species, and the prevalence is still increasing. In patients receiving broad-spectrum antibiotics or those with long-term urinary catheters, the clinical course of fungal UTI vary from being an asymptomatic and self-limiting disorder to fungal septicemia which can be fatal (5). All Candida species are capable of causing UTI, and in many centers worldwide, non-C. albicans species now predominate. Among Candida species, C. albicans is the most common isolated species according to epidemiological studies of fungal UTI. The newly emerging non-C. albicans, including C. glabrata is the agent of infections including UTI in hospitalized patients (6). A study of the prevalence of nosocomial candidiasis in Turkey, indicate that UTI with candida was in 57 (72.1%) patients and 16.14% of isolated candida were C. glabrata (7). Based on Freitas's survey on 95 yeasts isolated from nosocomial urinary infection, there were 31 (61.3%) C. glabrata (8).
What causes the difference in this case is that he had not been hospitalized although he has used urinary catheter for long term but he didn't has previous UTI or taking any antibiotics in his recent history and suddenly referred to" Brain and spinal injury repair research centre" with symptoms of fever and chill. In the microbiological investigation, there was pure C. glabrata culture in urine sample. The results of this survey indicated although C. glabrata is thought to be a primarily non-pathogenic organism but in this case with an injury on thoracic spinal cord region, it was a pathogen and caused symptomatic UTI.
References
1. Bethea EK, Carver BJ, Montedonico AE, et al. The inositol regulon controls viability in Candida glabrata. Microbiology 2010;156(2):452-62.
2. Rahimkhani M, Nikfallah A, Saberian M, et al. Urinary Tract Infection in Spinal Cord Injuries. Asian J Phamaceu Clin Res 2014;7(2):178-82.
3. Ploypetch T, Dajpratham P, Assanasen S, et al. Epidemiology of urinary tract infection among spinal cord injured patients in the rehabilitation ward at Siriraj Hospital. J Med Assoc Thai 2013;96(1):99-106.
4. Mishra M, Agrawal S, Raut S, et al. Profile of yeasts isolated from urinary tracts of catheterized patients. J Clin Diagn Res 2014;8(2):44-6.
5. Gubbins PO, Pisciteeli SC, Danziger LH. Candidal urinary tract infections: a comprehensive review of their diagnosis and management. Pharmacotherapy 1993;13(2):110-27.
6. Yismaw G, Asrat D, Woldeamanuel Y, et al. Prevalence of candiduria in diabetic patients attending Gondar University hospital, Gondar, Ethiopia. Iran J Kidney Dis 2013;7(2):102-7.
7. Erdem F, Tuncer Ertem G, Oral B, et al. Epidemiological and microbiological evaluation of nosocomial infections caused by Candida species. Mikrobiyol Bul 2012;46(4):637-48.
8. de Freitas AR, Baeza LC, Faria MG, et al. Yeasts isolated from nosocomial urinary infections: Antifungal susceptibility and biofilm production. Rev Iberoam Micol 2014;31(2):104-8.
Monireh Rahimkhani, Mostafa Saberian, Alireza Mordadi,
Sajad Varmazyar, and Ali Tavakoli
Department of Lab Medical Sciences, School of Allied Medical Sciences,
Tehran University of Medical Sciences, Tehran, Iran
Received: 11 Jun. 2014; Accepted: 12 Oct. 2014
Corresponding Author: M. Rahimkhani
Department of Lab Medical Sciences, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
Tel: +98 21 88957943, Fax: +98 21 88983037, E-mail address: [email protected]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright Tehran University of Medical Sciences Publications 2015